Roger S. Newton, Director at Esperion Therapeutics, Inc. (ESPR), sold 7,300 shares at $50.06 ($365K) on 2018-08-17, disclosed to the SEC on 2018-08-22.
Open-market sale of $365k ESPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ESPR | SELL | 2018-10-18 | $1.7M | — | Filing → |
| ESPR | SELL | 2018-08-29 | $904K | — | Filing → |
| ESPR | SELL | 2018-03-29 | $1.8M | — | Filing → |